NCT02070718View on ClinicalTrials.gov

Effects of a Kappa Agonist on Hot Flashes in Menopausal Women

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Treatment of Menopausal Hot Flashes
Interventions
DRUG

Standard Dose Kappa Agonist

DRUG

Half Dose Kappa Agonist

OTHER

Placebo

Trial Locations (1)

98195

University of Washington, Seattle

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

Office of Research on Women's Health (ORWH)

NIH

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

University of Washington

OTHER

NCT02070718 - Effects of a Kappa Agonist on Hot Flashes in Menopausal Women | Biotech Hunter | Biotech Hunter